Nanophase Announces $6M Financing

ROMEOVILLE, Ill., March 05, 2024 (GLOBE NEWSWIRE) — Nanophase Technologies Corporation (OTCQB:NANX), a leader in minerals-based and scientifically-driven health care solutions across beauty and life science categories — with innovations that protect skin from environmental aggressors and aid in medical diagnostics —announced today that it has concluded an equity financing in the amount of $6M with Strandler, LLC, an affiliate of its largest shareholder, Bradford T. Whitmore. The structure of the financing was in the form of convertible preferred stock. Strandler has purchased 15,000 shares of Nanophase Series X preferred shares, each of which will be convertible into 1,000 shares of Nanophase common stock. Pending shareholder approval of additional authorized common shares, and assuming conversion of all preferred shares, this will result in a total of 15,000,000 shares of Nanophase common stock being issued at an equivalent price of $0.40 per share. As part of the consideration for this deal, Strandler has agreed to hold the newly issued common shares for one year from the date of conversion, and, as additional consideration, Strandler, LLC and Beachcorp, LLC have both agreed to extend the maturity of the Company’s two existing revolving loans and one existing term loan to October 1, 2025. Both companies are affiliates of Bradford T. Whitmore, the Company’s largest shareholder.

Read more at globenewswire.com